Department of Family Medicine Research at Carolinas HealthCare System in Charlotte, NC is uniquely able to combine the three elements that make the study of population health possible:

  1. Access to patients across the full spectrum healthcare delivery – acute, post-acute, ambulatory and preventative care;
  2. Availability of integrated health and billing information from one of the nation's largest data warehouses; and
  3. Advanced analytic capabilities, including geographic information systems.

An Intensive Virtual Patient-Centered Medical Home Project

0/16/12 - 10/16/14 | In this study we are piloting the feasibility and effectiveness of providing intensive PCMH services to high-risk/high cost patients. Patients remain in their existing primary care home and care is directed by their existing PCP; however, wrap around PCMH services are provided from a centralized location and include: standard care pathways, multidisciplinary teams, and care coordination. The study also pilots the use of incentives to change healthcare utilization patterns.

Heart of a Champion

6/1/2009 – ongoing | A multidisciplinary project that provides pre-participation screening exams to high school athletes. Each athlete undergoes a standard history and physical, EKG, and an echo. This large cohort study monitors for the prevalence of conditions that place athletes at risk for sudden cardiac death. Multiple sub-studies are underway analyzing the best approach to screening athletes.

Learn more about Heart of a Champion

Implementing Personal Health Records to Promote Evidence-Based Cancer Screening

6/1/13 - 6/1/18 | This is a 2-phase mixed methods trial designed to assess implementation (Phase 1) and scalability (Phase 2) of a patient-centered, interactive preventive health record (IPHR). The IPHR is designed to promote adherence to evidence-based guidelines for cancer screening and shared decision-making. Embedded in Phase 1 is a “real-world” comparative effectiveness trial of traditional PHRs versus one with added IPHR functionality. Phase 1 (years 2-3) will include 23 control (traditional PHR) and 23 intervention (IPHR) practices.

In keeping with the RFP’s focus on implementation, Phase 2 (years 4-5) will include up to 278 practices and will involve a multi-level RE-AIM assessment: Adoption, Reach, Implementation, and Maintenance in the implementation/scalability assessments and Effectiveness in the comparative effectiveness trial. The experience of minorities and disadvantaged populations will be explicitly examined at all phases of the project. The randomized comparative effectiveness trial will test the following hypotheses: Patients in practices that use the IPHR will receive greater benefit than patients in practices that use a traditional PHR, with even greater benefits among IPHR-users than traditional PHR users, including:

  • Improved shared decision-making for cancer screening (Hypothesis 1).
  • Increased delivery of indicated cancer screening tests (Hypothesis 2).